Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  The International journal on drug policy

• Publication date

  2008-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.drugpo.2007.03.002PMID 18359216
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Knowledge about buprenorphine and methadone among those receiving treatment for opioid dependence

  2008cited by this paper
• Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment.

  2008cited by this paper
• Valuing methadone takeaway doses: The contribution of service-user perspectives to policy and practice

  2007cited by this paper
• Buprenorphine supply by community pharmacists in Victoria, Australia: perceptions, experiences and key issues identified.

  2007cited by this paper
• Regulatory challenges for new formulations of controlled substances in today's environment.

  2006cited by this paper
• Cycling in and out of treatment; participation in methadone treatment in NSW, 1990-2002.

  2006cited by this paper
• Australian Drug Trends 2004: Findings from the Illicit Drug Reporting System (IDRS)

  2006cited by this paper
• Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004.

  2005cited by this paper
• [Infectious complications and misuse of high-dose buprenorphine].

  2005cited by this paper
• The relationship between take-away methadone policies and methadone diversion.

  2005cited by this paper
• The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS).

  2005cited by this paper
• Unintentional methadone-related overdose death in New Mexico (USA) and implications for surveillance, 1998-2002.

  2005cited by this paper
• Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue?

  2005cited by this paper
• Complications infectieuses et mésusage de la buprénorphine à haut dosage

  2005cited by this paper
• Buprenorphine mortality, seizures and prescription data in the UK, 1980–2002

  2005cited by this paper
• A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths.

  2004cited by this paper
• Prevalence and correlates of intravenous methadone syrup administration in Adelaide, Australia.

  2003cited by this paper
• Groin tissue necrosis requiring skin graft following parenteral abuse of buprenorphine tablets.

  2003cited by this paper
• The National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results.

  2003cited by this paper
• Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France.

  2003cited by this paper
• The injection of methadone syrup in New South Wales: patterns of use and increased harm after partial banning of injecting equipment

  2003cited by this paper
• Illicit drug use and injection practices among drug users on methadone and buprenorphine maintenance treatment in France.

  2003cited by this paper
• A new series of 13 buprenorphine-related deaths.

  2002cited by this paper
• Fatal methadone toxicity: signs and circumstances, and the role of benzodiazepines

  2002cited by this paper
• The injection of methadone and benzodiazepines among Sydney injecting drug users 1996-2000: 5-year monitoring of trends from the Illicit Drug Reporting System.

  2002cited by this paper
• Deaths involving buprenorphine: a compendium of French cases.

  2001cited by this paper
• Recognizing and Preventing Medication Diversion

  2001cited by this paper
• Measuring alcohol consumption and alcohol-related problems: comparison of responses from self-administered questionnaires and telephone interviews.

  2001cited by this paper
• Recognizing preventing and medication diversion.

  2001cited by this paper
• Lethal methadone intoxications in Geneva, Switzerland, from 1994 to 1998.

  2000cited by this paper
• The effect of mode of data collection and of non-response on reported alcohol consumption: a split-sample study in Switzerland.

  2000cited by this paper
• Patients in methadone maintenance treatment who inject methadone syrup: a preliminary study.

  2000cited by this paper
• Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcome.

  2000cited by this paper
• Diversion of prescribed drugs by drug users in treatment: analysis of the UK market and new data from London.

  2000cited by this paper
• Deaths in methadone maintenance treatment in New South Wales, Australia 1990-1995.

  2000cited by this paper
• Methadone injecting in Australia: a tale of two cities.

  1999cited by this paper
• Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency.

  1998cited by this paper
• Eating Too Little, Smoking and Drinking Too Much: Wider Lifestyle Problems Among Methadone Maintenance Patients

  1998cited by this paper
• Controlled opioid withdrawal evaluation during 72 h dose omission in buprenorphine-maintained patients.

  1997cited by this paper
• Prevalence and correlates of the injection of methadone syrup in Sydney, Australia.

  1996cited by this paper
• Prohibition of take-home dosages: negative consequences on methadone maintenance treatment.

  1996cited by this paper
• "Non injectables": methadone syrup and benzodiazepine injection by methadone-maintained clients.

  1996cited by this paper
• Acute administration of buprenorphine in humans: partial agonist and blockade effects.

  1995cited by this paper
• Illicit use of methadone among i.v. drug users in Montreal.

  1994cited by this paper
• Clinical pharmacology of buprenorphine: Ceiling effects at high doses

  1994cited by this paper
• INTERVIEW MODE EFFECTS IN SURVEYS OF DRUG AND ALCOHOL USE: A FIELD EXPERIMENT

  1994cited by this paper

• Electronic Real-Time Monitoring Reveals Limited Adherence to Long-Term Opioid Prescriptions in Pain Patients

  2024cites this paper
• Oral Morphine as an Alternative Substitution Treatment for Opioid Use Disorder, a Rare but Non-risk-free Use

  2022cites this paper
• Buprenorphine and its formulations: a comprehensive review.

  2022cites this paper
• Methadone-related death in detention.

  2022cites this paper
• Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review

  2022cites this paper
• "People need them or else they're going to take fentanyl and die": A qualitative study examining the 'problem' of prescription opioid diversion during an overdose epidemic.

  2021cites this paper
• Balancing access to opioid substitution treatment with preventing the diversion of opioid substitution medications in Europe: challenges and implications

  2021cites this paper
• Assessing pharmacists' knowledge and compliance with narcotic inventory management using a computer-based educational platform.

  2021cites this paper
• 'We're just seen as people that give out the methadone…': exploring the role of community pharmacists in the opioid substitution treatment team.

  2020cites this paper
• Systematic benefit-risk assessment for buprenorphine implant: a semiquantitative method to support risk management

  2020cites this paper
• Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?

  2020cites this paper
• Risk assessment of using off‐label morphine sulfate in a population‐based retrospective cohort of opioid‐dependent patients

  2020cites this paper
• Buprenorphine implants: review of literature evidence and impacts on subjects with opioid use disorders

  2020cites this paper
• Association between Adult Attention Deficit/Hyperactivity Disorder and Intravenous Misuse of Opioid and Benzodiazepine in Patients under Opioid Maintenance Treatment: A Cross-Sectional Multicentre Study

  2020cites this paper
• Intravenous Misuse of Methadone, Buprenorphine and Buprenorphine-Naloxone in Patients Under Opioid Maintenance Treatment: A Cross-Sectional Multicentre Study

  2019cites this paper
• Évaluation de la douleur et du mésusage de la buprénorphine et de la méthadone chez les patients dépendants aux opioïdes substitués

  2019cites this paper
• Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities

  2019cites this paper
• Transdermal buprenorphine patch: Potential for role in management of opioid dependence.

  2019cites this paper
• Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment.

  2018cites this paper
• Challenges in implementing opioid agonist therapy in Lebanon: a qualitative study from a user’s perspective

  2018cites this paper
• Increasing diversion of methadone in Vancouver, Canada, 2005-2015.

  2018cites this paper
• ‘Discovering’ Non-Medical (Ab)Use: The Meaning and Measurement of Non-Medical Consumption

  2018cites this paper
• Restricting tobacco sales to only pharmacies combined with cessation advice: a modelling study of the future smoking prevalence, health and cost impacts

  2018cites this paper
• The source and diversion of pharmaceutical drugs for non-medical use: A systematic review and meta-analysis.

  2018cites this paper
• Effect of BuprenorphineWeekly Depot ( CAM 2038 ) and Hydromorphone Blockade in Individuals With Opioid Use Disorder A Randomized Clinical Trial

  2017cites this paper
• Advances in the delivery of buprenorphine for opioid dependence

  2017cites this paper
• Marijuana legalisation in the United States: An Australian perspective

  2017influential citation
• Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder: A Randomized Clinical Trial

  2017cites this paper
• Prescription opioid abuse in prison settings: A systematic review of prevalence, practice and treatment responses.

  2017cites this paper
• Buprenorphine implants in medical treatment of opioid addiction

  2017cites this paper
• Behavioral Characteristics and Injection Practices Associated with Skin and Soft Tissue Infections among People who Inject Drugs: A Community-Based Observational Study

  2017cites this paper
• The relationship between diversion-related attitudes and sharing and selling buprenorphine.

  2017cites this paper
• Quantitative Testing of Buprenorphine and Norbuprenorphine to Identify Urine Sample Spiking during Office-Based Opioid Treatment

  2017cites this paper
• Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

  2017cites this paper
• Probuphine® (buprenorphine implant): a promising candidate in opioid dependence

  2017cites this paper
• A comparison of privileged access interviewing and traditional interviewing methods when studying drug users in treatment

  2016cites this paper
• Risker och sidoeffekter i läkemedelsassisterad rehabilitering av opioidberoende – en forskningsöversikt

  2016cites this paper
• Incidence of high dosage buprenorphine and methadone shopping behavior in a retrospective cohort of opioid-maintained patients in France.

  2016cites this paper
• Pharmacists' different profiles characterization about opioid substitution treatments.

  2016cites this paper
• Factors associated with non-adherence and misuse of opioid maintenance treatment medications and intoxicating drugs among Finnish maintenance treatment patients.

  2016cites this paper
• Challenges and opportunities in using wastewater analysis to measure drug use in a small prison facility.

  2016cites this paper
• [Trend in buprenorphine and methadone shopping behavior in France from 2004 to 2014].

  2016cites this paper
• Buprenorphine Implants: Review of Clinical Studies

  2015cites this paper
• Diversion of opioid maintenance treatment medications and predictors for diversion among Finnish maintenance treatment patients.

  2015cites this paper
• Current Status of Buprenorphine/Naloxone Maintenance Treatment in Istanbul Turkey

  2015cites this paper
• Opioid Agonist Diversion in Opioid-Dependence Treatment

  2015cites this paper
• Opioid-dependence treatment in the era of recovery: insights from a UK survey of physicians, patients and out-of-treatment opioid users

  2015cites this paper
• Nutritional intake of opioid replacement therapy patients in community pharmacies: A pilot study

  2015cites this paper
• Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia.

  2015cites this paper
• Drug and alcohol addiction: new pharmacotherapies

  2015cites this paper
• Diversion of methadone and buprenorphine by patients in opioid substitution treatment in Sweden: prevalence estimates and risk factors.

  2015cites this paper
• Injecting buprenorphine-naloxone film: Findings from an explorative qualitative study.

  2015cites this paper
• Buprenorphine–naloxone buccal soluble film for the treatment of opioid dependence: current update

  2015cites this paper
• Diversion of methadone and buprenorphine from opioid substitution treatment: the importance of patients' attitudes and norms.

  2015cites this paper
• Diversion of Methadone and Buprenorphine from Opioid Substitution Treatment: Patients who Regularly Sell or Share Their Medication

  2015cites this paper
• Validity of Self-Reported Drug Use Information Among Pregnant Women

  2015cites this paper
• A latent class analysis of self-reported clinical indicators of psychosocial stability and adherence among opioid substitution therapy patients: do stable patients receive more unsupervised doses?

  2014cites this paper
• Buprenorphine Use and Risk of Abuse and Diversion

  2014cites this paper
• Monitoring substance use in prisons: Assessing the potential value of wastewater analysis.

  2014cites this paper
• Factors associated with buprenorphine compared to amphetamine abuse among clients seeking treatment in Finland.

  2014cites this paper
• Use and diversion of illicit methadone – under what circumstances does it occur, and potential risks associated with continued use of other substances

  2014cites this paper
• Crushed and Injected Buprenorphine Tablets: Characteristics of Princeps and Generic Solutions

  2014cites this paper
• Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial.

  2013cites this paper
• Long Term Suboxone™ Emotional Reactivity As Measured by Automatic Detection in Speech

  2013cites this paper
• The effect of an electronic medicine dispenser on diversion of buprenorphine-naloxone-experience from a medium-sized Finnish city.

  2013cites this paper
• Improving maintenance treatment of opiate addiction: Clinical aspects

  2013cites this paper
• Drug treatment practitioners’ perceptions of methadone diversion and their responses to it

  2013cites this paper
• A randomised controlled trial of sublingual buprenorphine-naloxone film versus tablets in the management of opioid dependence.

  2013cites this paper
• Treatment of opioid dependence

  2013cites this paper
• Self-reported psychopathology and health-related quality of life in heroin users treated with methadone

  2012cites this paper
• Buprenorphine and buprenorphine/naloxone soluble-film for treatment of opioid dependence

  2012cites this paper
• Buprenorphine vs methadone treatment: A review of evidence in both developed and developing worlds

  2012cites this paper
• The nature of methadone diversion in England: a Merseyside case study

  2012cites this paper
• Buprenorphine/Naloxone for opioid dependence: clinical practice guideline.

  2011cites this paper
• Royal College of General Practitioners Guidance for the use of substitute prescribing in the treatment of opioid dependence in primary care

  2011cites this paper
• Methadone disposition in oral fluid during pharmacotherapy for opioid-dependence.

  2011cites this paper
• Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients.

  2011influential citation
• Post-marketing surveillance of buprenorphine-naloxone in Australia: diversion, injection and adherence with supervised dosing.

  2011cites this paper
• Opioid replacement therapy: a wait unmanaged.

  2011cites this paper
• Variations in treatment organisation, practices and outcomes within the Norwegian Opioid Maintenance Treatment Programme

  2011cites this paper
• Provision of opioid substitution therapy services in Australian pharmacies.

  2011cites this paper
• Diversion and Injection of Methadone and Buprenorphine Among Clients in Public Opioid Treatment Clinics in New South Wales, Australia

  2010influential citation
• Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial.

  2010cites this paper
• Neurobiologie de la toxicomanie : avancées récentes et nouvelles stratégies d’intervention

  2010cites this paper
• Self-treatment: illicit buprenorphine use by opioid-dependent treatment seekers.

  2010cites this paper
• Use of Street Methadone in Italian Heroin Addicts Presenting for Opioid Agonist Treatment

  2009cites this paper
• Exploring prison buprenorphine misuse in the United Kingdom: a qualitative study of former prisoners.

  2009cites this paper
• Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist–antagonist formulation

  2009cites this paper
• Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist – antagonist formulation

  2009cites this paper
• Why Do the Clients of Georgian Needle Exchange Programmes Inject Buprenorphine?

  2009cites this paper
• Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence

  2009cites this paper
• THE DIVERSION AND INJECTION OF THE PHARMACEUTICAL OPIOIDS USED IN OPIOID SUBSTITUTION TREATMENT: Findings from the Australian post-marketing surveillance studies of buprenorphine-naloxone, 2006-2008

  2009cites this paper
• What Is Diversion of Supervised Buprenorphine and How Common Is It?

  2009cites this paper
• Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatment.

  2008cites this paper